Form 8-K - Current report:
SEC Accession No. 0001437749-23-003535
Filing Date
2023-02-15
Accepted
2023-02-15 17:00:24
Documents
13
Period of Report
2023-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bkyi20230215_8k.htm   iXBRL 8-K 19251
  Complete submission text file 0001437749-23-003535.txt   150217

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bkyi-20230209.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkyi-20230209_def.xml EX-101.DEF 11532
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkyi-20230209_lab.xml EX-101.LAB 15414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkyi-20230209_pre.xml EX-101.PRE 11688
7 EXTRACTED XBRL INSTANCE DOCUMENT bkyi20230215_8k_htm.xml XML 2568
Mailing Address 3349 HIGHWAY 138 BUIDING A, SUITE E WALL NJ 07719
Business Address 3349 HIGHWAY 138 BUIDING A, SUITE E WALL NJ 07719 7323591100
BIO KEY INTERNATIONAL INC (Filer) CIK: 0001019034 (see all company filings)

EIN.: 411761861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13463 | Film No.: 23636190
SIC: 7372 Services-Prepackaged Software